AF
ZBH icon

Arrow Financial’s Zimmer Biomet ZBH Stock Holding History

Arrow Financial’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-720
Closed -$77.7K – 330
2024
Q3 		$77.7K Hold
720
– – 0.01% 203
2024
Q2 		$78.1K Hold
720
– – 0.01% 194
2024
Q1 		$95K Sell
720
-33
-4% -$4.12K 0.01% 182
2023
Q4 		$91.6K Buy
753
+23
+3% +$2.57K 0.01% 184
2023
Q3 		$81.9K Sell
730
-25
-3% -$3.17K 0.01% 190
2023
Q2 		$110K Sell
755
-40
-5% -$5.44K 0.01% 172
2023
Q1 		$103K Sell
795
-225
-22% -$28.2K 0.01% 176
2022
Q4 		$130K Hold
1,020
– – 0.02% 166
2022
Q3 		$106K Hold
1,020
– – 0.02% 174
2022
Q2 		$107K Sell
1,020
-175
-15% -$20.8K 0.01% 175
2022
Q1 		$153K Sell
1,195
-118
-9% -$14.2K 0.02% 169
2021
Q4 		$162K Sell
1,313
-83
-6% -$10.9K 0.02% 169
2021
Q3 		$198K Hold
1,396
– – 0.03% 163
2021
Q2 		$218K Sell
1,396
-134
-9% -$21.7K 0.03% 162
2021
Q1 		$238K Sell
1,530
-77
-5% -$11.9K 0.03% 161
2020
Q4 		$241K Sell
1,607
-82
-5% -$11.6K 0.05% 147
2020
Q3 		$223K Sell
1,689
-103
-6% -$13.5K 0.05% 144
2020
Q2 		$208K Sell
1,792
-103
-5% -$11.9K 0.05% 147
2020
Q1 		$186K Sell
1,895
-129
-6% -$16.9K 0.04% 150
2019
Q4 		$294K Sell
2,024
-265
-12% -$36.6K 0.06% 144
2019
Q3 		$304K Sell
2,289
-128
-5% -$16.5K 0.06% 145
2019
Q2 		$276K Sell
2,417
-531
-18% -$62.2K 0.06% 153
2019
Q1 		$366K Sell
2,948
-103
-3% -$11.7K 0.08% 138
2018
Q4 		$308K Buy
3,051
+273
+10% +$30.7K 0.08% 145
2018
Q3 		$354K Buy
2,778
+288
+12% +$34.2K 0.07% 149
2018
Q2 		$269K Hold
2,490
– – 0.06% 153
2018
Q1 		$263K Hold
2,490
– – 0.06% 154
2017
Q4 		$291K Hold
2,490
– – 0.07% 146
2017
Q3 		$283K Hold
2,490
– – 0.07% 146
2017
Q2 		$311K Sell
2,490
-8
-0.3% -$948 0.07% 147
2017
Q1 		$296K Hold
2,498
– – 0.07% 144
2016
Q4 		$251K Hold
2,498
– – 0.06% 145
2016
Q3 		$316K Hold
2,498
– – 0.08% 139
2016
Q2 		$292K Hold
2,498
– – 0.08% 145
2016
Q1 		$259K Sell
2,498
-335
-12% -$32.4K 0.07% 145
2015
Q4 		$282K Sell
2,833
-77
-3% -$7.53K 0.08% 138
2015
Q3 		$265K Sell
2,910
-77
-3% -$7.72K 0.08% 141
2015
Q2 		$317K Sell
2,987
-1,566
-34% -$173K 0.09% 141
2015
Q1 		$520K Sell
4,553
-592
-12% -$67.5K 0.14% 130
2014
Q4 		$567K Sell
5,145
-257
-5% -$27.1K 0.15% 125
2014
Q3 		$528K Sell
5,402
-52
-1% -$5.12K 0.15% 132
2014
Q2 		$550K Sell
5,454
-541
-9% -$52.8K 0.15% 135
2014
Q1 		$550K Sell
5,995
-257
-4% -$23.7K 0.16% 131
2013
Q4 		$566K Sell
6,252
-180
-3% -$15.6K 0.16% 125
2013
Q3 		$513K Sell
6,432
-67
-1% -$5.27K 0.16% 123
2013
Q2 		$473K Buy
+6,499
New +$486K 0.15% 123

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Arrow Financial's ZBH Position: Q4 2024 in Review

Arrow Financial sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 720 shares — an estimated $77.7K sold.

Arrow Financial first reported a position in ZBH in Q2 2013 and held it in 46 quarters. The position peaked at $567K in Q4 2014. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Arrow Financial reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Arrow Financial sold 720 Zimmer Biomet shares in Q4 2024, an estimated $77.7K.
  • Arrow Financial first reported a position in Zimmer Biomet in Q2 2013 and held it in 46 quarters.
  • Arrow Financial's Zimmer Biomet position peaked at $567K in Q4 2014.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.